As with other GLP-1 receptor agonists, liraglutide stimulates insulin secretion and lessens glucagon secretion in the glucose-dependent way. These effects can result in a reduction of blood glucose. Physique weight noticeably impacts the pharmacokinetics of liraglutide according to results of inh